Substance use disorder treatment Market Size & Trends-2032

Request Methodology

Substance Use Disorder Treatment Market Outlook (2022-2032)

[323 Pages Report] The global substance use disorder treatment market is forecasted to be estimated at US$ 14 Mn by 2032, up from US$ 7 Mn in 2022, advancing at a CAGR of 5.4% during the forecast period.

An increasing number of treatment centers, with mergers with private recovery institutions to aid in the extension of treatment access to a wide range of people is likely to accelerate market growth. However, the high cost of substance use disorder treatment therapy is likely to hamper the market size in developing economies due to patients having a limited income.

On the contrary, surging initiatives and funding by the government for the awareness and treatment of chronic-ill effects of substance abuse is likely to expand the substance use disorder treatment market size during the forecast period.

Report Attribute	Details
Substance Use Disorder Treatment Market Value (2022)	US$ 7 million
Substance Use Disorder Treatment Market Anticipated Value (2032)	US$ 14 million
Substance Use Disorder Treatment Projected Growth Rate (2032)	5.4%

The substance use disorder treatment market is likely to expand due to the growth in the use of tobacco in developing and underdeveloped countries, especially in the Pacific and East Asian countries. Moreover, the implementation of strategic initiatives amongst several market players is expected to drive market growth further.

Favourable reimbursement policies and treatment advancements due to the psychological effects of substance abuse are anticipated to surge the market share. Furthermore, government investments in technology and telecommunication to improve the healthcare infrastructure is likely to contribute to market growth.

Prevention programs and increasing drug awareness crusades to provide information on the risks of mixing drugs and the stigma around drug use to support treatment and recovery are expected to propel the market share. These include a higher treatment-seeking rate, increased government intervention, encouragement to curb substance abuse, and increased patient awareness.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Technological Advancements Bring the Treatment to New Horizons

Technological advancements surging the production of digital devices is likely to aid in substance use disorder treatment. Hence, the increasing penetration of digitization is positively impacting the market share.

The substance use disorder treatment market size is expected to increase using government support. In addition, ‘The Confidentiality of Substance Use Disorder Patient Records Regulation’ assures confidentiality for individuals being treated for substance use disorder treatment, which is expected to boost the market growth.

Increasing awareness about the dangerous aftermath of alcohol abuse and the rise in the number of rehabilitation facilities are forecasted to propel the market. Moreover, the wide variety of options for alcohol addiction treatment, such as counselling, group therapy, and medication, are anticipated to bolster the substance use disorder treatment market.

Drug compounding catering to the need of every individual patient significantly boosts the global market growth. Furthermore, the demand for substance use disorder treatment is likely to rise owing to the presence of experienced psychologists to conduct therapy and skilled professionals capable of executing drug compounding.

The awareness about the impact of substance use disorder through various campaigns by non-profit organizations and governments through advertisements on television, newspapers, magazines, etc., has witnessed remarkable growth. This is estimated to expand the market size.

Reluctance to Opt for Treatment to be a Key Market Impeder

Poor treatment compliance in some countries and the reluctance of individuals to access treatment modalities are likely to hinder the market growth. Likewise, the market is expected to impede due to the discontinuation of behavioural therapies leading to relapse and patients opting for outpatient care.

Extending periods of clinical trials, as well as incomplete health treatment programs, are expected to obstruct the market share. Similarly, inadequate services for treating substance abuse present a significant challenge for the market.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Revenue Opportunities for the Substance Use Disorder Treatment Market?

The high prevalence of comorbid illnesses is accountable to wrong prescription drugs. Therefore, the rising consumption of non-medical prescription drugs and increasing overdose deaths are expected to propel market growth in the coming years.

The high proportion of e-cigarette users in urban areas provides a lucrative opportunity for the substance use disorder treatment market. This is owing to research on E-cigarettes that estimated several major health issues linked with tobacco use.

How is the Performance of the North America Substance Use Disorder Treatment Market?

North America is the most dominating substance use disorder treatment market, with a significant share of 46.7% in 2022. This is owing to the surge in government initiatives aimed at reducing substance abuse, as well as the rise in tobacco use.

The dependence of about 20 Mn people on both alcohol and illicit drugs in the U.S is likely to drive the market growth. Moreover, mental illness as a consequence of drug abuse is further expected to expand the market size in this region.

The consolidation of smaller rehabilitation centres by major rehab centres providing uniformity in treatment patterns bolsters the market share in this region. Additionally, the expansion of rehab centres and their increasing capacity is anticipated to drive the demand for substance use disorder treatment.

How will the Europe Substance Use Disorder Treatment Market Grow?

With a revenue share of 37.4% in 2022, Europe is another dominating substance use disorder market. This is attributed to the massive rise in cases of substance abuse and a profusion of government initiatives.

The rising prevalence of alcohol abuse amongst the majority of the population, leading to disturbing behavioural patterns, is expected to drive the market. Moreover, increasing death rates due to drug overdose or alcohol intoxication is likely to further contribute to market growth.

What is the Growth Outlook for the Asia Pacific Substance Use Disorder Treatment Market?

The Asia Pacific is a growing substance use disorder market attributed to the rising healthcare expenditure and awareness about the aftermath of substance abuse.

Nicotine addiction is the highest substance use disorder in this region. Thus, it is likely to significantly contribute to the global market's growth.

Start-Up Companies to Watch for in the Substance Use Disorder Treatment Market

People face multiple challenges in trying to break the habit of substance dependency. Due to widely available purchases from local pharmacies, narcotic substances are responsible for various physical and psychological illnesses. Significant developments in digital health, augmented reality (AR), and virtual reality (VR) assist start-up companies in developing original and creative solutions for managing addiction.

Several start-up companies are generating their own approach to substance abuse treatment.

zpharm - They offer Cravv, which is a natural health product for smoking cessation.
PursueCare - They provide at-home telehealth treatment for opioid addiction.
Virtual Rehab – They strive to combine VR and evidence-based solutions to improve mental health and well-being for people battling addiction.
Amygdala Neurosciences - They are developing a new chemical entity, selective and reversible mitochondrial aldehyde dehydrogenase 2 (ALDH2) inhibitor.
Kinoxis Therapeutic - They are working to develop a range of therapeutic compounds for the treatment of substance use disorders and other central nervous systems (CNS) conditions.

What is the Competitive Landscape of the Substance Use Disorder Treatment Market?

Key market participants are continually educating themselves to develop a deeper understanding of psychological issues in people, emerging from prolonged substance abuse. Through mergers and acquisitions, along with increasing awareness through campaigns, they are coming up with enhanced treatment options.

Key market players of the substance use disorder treatment market

Teva Pharmaceutical Industries Ltd. - Their mission is to be a global leader in generics and biopharmaceutical medicines, improving the lives of patients around the world.
Reckitt Benckiser Pharmaceuticals Inc. – They are a brand that focuses on cleanliness and hygiene. They are the makers of Dettol, Durex, Harpic, Lysol and Mortein among many other brands.
GlaxoSmithKline plc – They are a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of diseases.
Pfizer Inc. – They are an American multinational pharmaceutical and biotechnology corporation headquartered in Manhattan, New York. They develop and produce medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.

Other market players of the substance use disorder treatment market:

Cipla Limited
Intas Biopharmaceuticals
Alkermes
Allergan plc
Alkermes plc.
Indivior plc
Noramco
Mallinckrodt plc
BioCorRx Inc.
Glenmark Pharmaceuticals Ltd.
Dr. Reddy’s Laboratories
Purdue Pharma L.P.
Orexo AB

Some of the recent developments in the substance use disorder treatment market are

In June 2021, Indivior plc and Aelis Farma announced a strategic partnership and option-license agreement to address significant repercussions of cannabis use disorders (CUD), including cannabis-induced psychosis (CIP).
In May 2021, JB Chemicals & Pharmaceuticals Ltd. launched NOSMOK prescription medicated nicotine lozenges as part of a 360 Tobacco Cessation initiative on ‘World No Tobacco Day’ that will aid in reducing the urge to consume tobacco.
In November 2018, Sandoz announced the commercial launch of reSET for patients with Substance Use Disorder (SUD).
In May 2018, US WorldMeds LLC, received the U.S. Food & Drug Administration approval for Lucemyra (Iofexidine hydrochloride), the first ever non-opioid based treatment used for management of opioid withdrawal symptoms in adults.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 5.4% from 2022 to 2032
Base year for estimation	2021
Historical data	2016 - 2021
Forecast period	2022 - 2032
Quantitative units	Revenue in USD million and CAGR from 2022 to 2032
Report coverage	Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis
Segments covered	Type, Treatment, and Region
Regional scope	North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope	USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled	Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Pharmaceuticals Inc., GlaxoSmithKline plc, Alkermes plc., Pfizer Inc., Cipla Limited, Intas Biopharmaceuticals, Alkermes, Allergan plc, Indivior plc, Noramco, Mallinckrodt plc, BioCorRx Inc., Glenmark Pharmaceuticals Ltd., Dr. Reddy’s Laboratories, Purdue Pharma L.P., Orexo AB, etc.
Customization scope	Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.

Key Segments Profiled in the Substance Use Disorder Treatment Market Survey

By Type:

Alcohol Abuse Treatment
Nicotine Abuse Treatment
Drug Abuse Treatment

By Treatment:

Detoxification
Counselling & Behavioural Therapy
Medication
Support Group

By Region:

North America
Latin America
Asia Pacific
MEA
Europe

Frequently Asked Questions

How much CAGR can be Approximated for the Substance Use Disorder Treatment Market?

The substance use disorder treatment market is anticipated to generate a CAGR of 5.4% during the forecast period.

What is the Major Restraint of the Substance Use Disorder Treatment Market?

Discontinuation of behavioural therapies leading to relapse, and patients opting for outpatient care.

What will be the Size of the Substance Use Disorder Treatment Market?

By 2032, the market is likely to grow to a revenue of US$ 14 Mn.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2017-2021

5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2022-2032

5.3.1. Alcohol Abuse Treatment

5.3.2. Nicotine Abuse Treatment

5.3.3. Drug Abuse Treatment

5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021

5.5. Absolute $ Opportunity Analysis By Type, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Treatment

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Mn) Analysis By Treatment, 2017-2021

6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Treatment, 2022-2032

6.3.1. Detoxification

6.3.2. Counselling & Behavioral Therapy

6.3.3. Medication

6.3.4. Support Group

6.4. Y-o-Y Growth Trend Analysis By Treatment, 2017-2021

6.5. Absolute $ Opportunity Analysis By Treatment, 2022-2032

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

7.1. Introduction

7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

7.3.1. North America

7.3.2. Latin America

7.3.3. Europe

7.3.4. Asia Pacific

7.3.5. MEA

7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

8.2.1. By Country

8.2.1.1. US

8.2.1.2. Canada

8.2.2. By Type

8.2.3. By Treatment

8.3. Market Attractiveness Analysis

8.3.1. By Country

8.3.2. By Type

8.3.3. By Treatment

8.4. Key Takeaways

9. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

9.2.1. By Country

9.2.1.1. Brazil

9.2.1.2. Mexico

9.2.1.3. Rest of Latin America

9.2.2. By Type

9.2.3. By Treatment

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Type

9.3.3. By Treatment

9.4. Key Takeaways

10. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

10.2.1. By Country

10.2.1.1. Germany

10.2.1.2. U.K.

10.2.1.3. France

10.2.1.4. Spain

10.2.1.5. Italy

10.2.1.6. Rest of Europe

10.2.2. By Type

10.2.3. By Treatment

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Type

10.3.3. By Treatment

10.4. Key Takeaways

11. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

11.2.1. By Country

11.2.1.1. China

11.2.1.2. Japan

11.2.1.3. South Korea

11.2.1.4. Rest of Asia Pacific

11.2.2. By Type

11.2.3. By Treatment

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Type

11.3.3. By Treatment

11.4. Key Takeaways

12. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

12.2.1. By Country

12.2.1.1. GCC Countries

12.2.1.2. South Africa

12.2.1.3. Israel

12.2.1.4. Rest of MEA

12.2.2. By Type

12.2.3. By Treatment

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Type

12.3.3. By Treatment

12.4. Key Takeaways

13. Key Countries Market Analysis

13.1. US

13.1.1. Pricing Analysis

13.1.2. Market Share Analysis, 2021

13.1.2.1. By Type

13.1.2.2. By Treatment

13.2. Canada

13.2.1. Pricing Analysis

13.2.2. Market Share Analysis, 2021

13.2.2.1. By Type

13.2.2.2. By Treatment

13.3. Brazil

13.3.1. Pricing Analysis

13.3.2. Market Share Analysis, 2021

13.3.2.1. By Type

13.3.2.2. By Treatment

13.4. Mexico

13.4.1. Pricing Analysis

13.4.2. Market Share Analysis, 2021

13.4.2.1. By Type

13.4.2.2. By Treatment

13.5. Germany

13.5.1. Pricing Analysis

13.5.2. Market Share Analysis, 2021

13.5.2.1. By Type

13.5.2.2. By Treatment

13.6. U.K.

13.6.1. Pricing Analysis

13.6.2. Market Share Analysis, 2021

13.6.2.1. By Type

13.6.2.2. By Treatment

13.7. France

13.7.1. Pricing Analysis

13.7.2. Market Share Analysis, 2021

13.7.2.1. By Type

13.7.2.2. By Treatment

13.8. Spain

13.8.1. Pricing Analysis

13.8.2. Market Share Analysis, 2021

13.8.2.1. By Type

13.8.2.2. By Treatment

13.9. Italy

13.9.1. Pricing Analysis

13.9.2. Market Share Analysis, 2021

13.9.2.1. By Type

13.9.2.2. By Treatment

13.10. China

13.10.1. Pricing Analysis

13.10.2. Market Share Analysis, 2021

13.10.2.1. By Type

13.10.2.2. By Treatment

13.11. Japan

13.11.1. Pricing Analysis

13.11.2. Market Share Analysis, 2021

13.11.2.1. By Type

13.11.2.2. By Treatment

13.12. South Korea

13.12.1. Pricing Analysis

13.12.2. Market Share Analysis, 2021

13.12.2.1. By Type

13.12.2.2. By Treatment

13.13. GCC Countries

13.13.1. Pricing Analysis

13.13.2. Market Share Analysis, 2021

13.13.2.1. By Type

13.13.2.2. By Treatment

13.14. South Africa

13.14.1. Pricing Analysis

13.14.2. Market Share Analysis, 2021

13.14.2.1. By Type

13.14.2.2. By Treatment

13.15. Israel

13.15.1. Pricing Analysis

13.15.2. Market Share Analysis, 2021

13.15.2.1. By Type

13.15.2.2. By Treatment

14. Market Structure Analysis

14.1. Competition Dashboard

14.2. Competition Benchmarking

14.3. Market Share Analysis of Top Players

14.3.1. By Regional

14.3.2. By Type

14.3.3. By Treatment

15. Competition Analysis

15.1. Competition Deep Dive

15.1.1. Teva Pharmaceutical Industries

15.1.1.1. Overview

15.1.1.2. Product Portfolio

15.1.1.3. Profitability by Market Segments

15.1.1.4. Sales Footprint

15.1.1.5. Strategy Overview

15.1.1.5.1. Marketing Strategy

15.1.2. Reckitt Benckiser Pharmaceuticals

15.1.2.1. Overview

15.1.2.2. Product Portfolio

15.1.2.3. Profitability by Market Segments

15.1.2.4. Sales Footprint

15.1.2.5. Strategy Overview

15.1.2.5.1. Marketing Strategy

15.1.3. GlaxoSmithKline plc

15.1.3.1. Overview

15.1.3.2. Product Portfolio

15.1.3.3. Profitability by Market Segments

15.1.3.4. Sales Footprint

15.1.3.5. Strategy Overview

15.1.3.5.1. Marketing Strategy

15.1.4. Alkermes plc

15.1.4.1. Overview

15.1.4.2. Product Portfolio

15.1.4.3. Profitability by Market Segments

15.1.4.4. Sales Footprint

15.1.4.5. Strategy Overview

15.1.4.5.1. Marketing Strategy

15.1.5. Pfizer, Inc.

15.1.5.1. Overview

15.1.5.2. Product Portfolio

15.1.5.3. Profitability by Market Segments

15.1.5.4. Sales Footprint

15.1.5.5. Strategy Overview

15.1.5.5.1. Marketing Strategy

15.1.6. Cipla Limited

15.1.6.1. Overview

15.1.6.2. Product Portfolio

15.1.6.3. Profitability by Market Segments

15.1.6.4. Sales Footprint

15.1.6.5. Strategy Overview

15.1.6.5.1. Marketing Strategy

15.1.7. Intas Biopharmaceuticals

15.1.7.1. Overview

15.1.7.2. Product Portfolio

15.1.7.3. Profitability by Market Segments

15.1.7.4. Sales Footprint

15.1.7.5. Strategy Overview

15.1.7.5.1. Marketing Strategy

15.1.8. Dr. Reddy’s Laboratories

15.1.8.1. Overview

15.1.8.2. Product Portfolio

15.1.8.3. Profitability by Market Segments

15.1.8.4. Sales Footprint

15.1.8.5. Strategy Overview

15.1.8.5.1. Marketing Strategy

15.1.9. Mylan

15.1.9.1. Overview

15.1.9.2. Product Portfolio

15.1.9.3. Profitability by Market Segments

15.1.9.4. Sales Footprint

15.1.9.5. Strategy Overview

15.1.9.5.1. Marketing Strategy

15.1.10. Novartis

15.1.10.1. Overview

15.1.10.2. Product Portfolio

15.1.10.3. Profitability by Market Segments

15.1.10.4. Sales Footprint

15.1.10.5. Strategy Overview

15.1.10.5.1. Marketing Strategy

15.1.11. Noramco

15.1.11.1. Overview

15.1.11.2. Product Portfolio

15.1.11.3. Profitability by Market Segments

15.1.11.4. Sales Footprint

15.1.11.5. Strategy Overview

15.1.11.5.1. Marketing Strategy

15.1.12. Mallinckrodt plc

15.1.12.1. Overview

15.1.12.2. Product Portfolio

15.1.12.3. Profitability by Market Segments

15.1.12.4. Sales Footprint

15.1.12.5. Strategy Overview

15.1.12.5.1. Marketing Strategy

15.1.13. Glenmark

15.1.13.1. Overview

15.1.13.2. Product Portfolio

15.1.13.3. Profitability by Market Segments

15.1.13.4. Sales Footprint

15.1.13.5. Strategy Overview

15.1.13.5.1. Marketing Strategy

15.1.14. Indivior

15.1.14.1. Overview

15.1.14.2. Product Portfolio

15.1.14.3. Profitability by Market Segments

15.1.14.4. Sales Footprint

15.1.14.5. Strategy Overview

15.1.14.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 3: Global Market Value (US$ Mn) Forecast by Treatment, 2017-2032

Table 4: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 5: North America Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 6: North America Market Value (US$ Mn) Forecast by Treatment, 2017-2032

Table 7: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: Latin America Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 9: Latin America Market Value (US$ Mn) Forecast by Treatment, 2017-2032

Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 11: Europe Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 12: Europe Market Value (US$ Mn) Forecast by Treatment, 2017-2032

Table 13: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Asia Pacific Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 15: Asia Pacific Market Value (US$ Mn) Forecast by Treatment, 2017-2032

Table 16: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: MEA Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 18: MEA Market Value (US$ Mn) Forecast by Treatment, 2017-2032

List of Charts

Figure 1: Global Market Value (US$ Mn) by Type, 2022-2032

Figure 2: Global Market Value (US$ Mn) by Treatment, 2022-2032

Figure 3: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 8: Global Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 9: Global Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 10: Global Market Value (US$ Mn) Analysis by Treatment, 2017-2032

Figure 11: Global Market Value Share (%) and BPS Analysis by Treatment, 2022-2032

Figure 12: Global Market Y-o-Y Growth (%) Projections by Treatment, 2022-2032

Figure 13: Global Market Attractiveness by Type, 2022-2032

Figure 14: Global Market Attractiveness by Treatment, 2022-2032

Figure 15: Global Market Attractiveness by Region, 2022-2032

Figure 16: North America Market Value (US$ Mn) by Type, 2022-2032

Figure 17: North America Market Value (US$ Mn) by Treatment, 2022-2032

Figure 18: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 23: North America Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 24: North America Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 25: North America Market Value (US$ Mn) Analysis by Treatment, 2017-2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Treatment, 2022-2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Treatment, 2022-2032

Figure 28: North America Market Attractiveness by Type, 2022-2032

Figure 29: North America Market Attractiveness by Treatment, 2022-2032

Figure 30: North America Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Market Value (US$ Mn) by Type, 2022-2032

Figure 32: Latin America Market Value (US$ Mn) by Treatment, 2022-2032

Figure 33: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 40: Latin America Market Value (US$ Mn) Analysis by Treatment, 2017-2032

Figure 41: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2022-2032

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2022-2032

Figure 43: Latin America Market Attractiveness by Type, 2022-2032

Figure 44: Latin America Market Attractiveness by Treatment, 2022-2032

Figure 45: Latin America Market Attractiveness by Country, 2022-2032

Figure 46: Europe Market Value (US$ Mn) by Type, 2022-2032

Figure 47: Europe Market Value (US$ Mn) by Treatment, 2022-2032

Figure 48: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 53: Europe Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 54: Europe Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 55: Europe Market Value (US$ Mn) Analysis by Treatment, 2017-2032

Figure 56: Europe Market Value Share (%) and BPS Analysis by Treatment, 2022-2032

Figure 57: Europe Market Y-o-Y Growth (%) Projections by Treatment, 2022-2032

Figure 58: Europe Market Attractiveness by Type, 2022-2032

Figure 59: Europe Market Attractiveness by Treatment, 2022-2032

Figure 60: Europe Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Market Value (US$ Mn) by Type, 2022-2032

Figure 62: Asia Pacific Market Value (US$ Mn) by Treatment, 2022-2032

Figure 63: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 70: Asia Pacific Market Value (US$ Mn) Analysis by Treatment, 2017-2032

Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by Treatment, 2022-2032

Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2022-2032

Figure 73: Asia Pacific Market Attractiveness by Type, 2022-2032

Figure 74: Asia Pacific Market Attractiveness by Treatment, 2022-2032

Figure 75: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 76: MEA Market Value (US$ Mn) by Type, 2022-2032

Figure 77: MEA Market Value (US$ Mn) by Treatment, 2022-2032

Figure 78: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 79: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 83: MEA Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 84: MEA Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 85: MEA Market Value (US$ Mn) Analysis by Treatment, 2017-2032

Figure 86: MEA Market Value Share (%) and BPS Analysis by Treatment, 2022-2032

Figure 87: MEA Market Y-o-Y Growth (%) Projections by Treatment, 2022-2032

Figure 88: MEA Market Attractiveness by Type, 2022-2032

Figure 89: MEA Market Attractiveness by Treatment, 2022-2032

Figure 90: MEA Market Attractiveness by Country, 2022-2032

January 2018

REP-GB-6008

August 2022

323 pages

Healthcare

Sabyasachi Ghosh

Book Now

Clients

Customize This Research

Quick Contact

Chat on Whatsapp + 44 (0) 20 3287 4268 + 44 (0) 20 8123 9659 + 1 347 918 3531 Contact By Email

- Trust FMI -

- Member of -

Greater New York Chamber of Commerce

- Awarded by -

BRONZE STEVIE® Award

20th annual IBAs

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

- Recognized by -

Substance Use Disorder Treatment Market

Substance use disorder treatment Market By Type, Treatment & Region- Forecast 2022 – 2032